Sarah Kostiuk-Smith, Partner and Patent Attorney at Mewburn Ellis, joins Forward Editor Caitlin Mackesy Davies to tackle the topic of patent validation strategies, focusing on the pharmaceutical sector in Europe. Sarah gives us a glimpse into the key findings of the Special Report she has recently co-authored on the topic, along with the reasons why it will be of interest to pharmaceutical firms ranging from Big Pharma down to small innovative start-ups.
Listen time: 11 minutes
- Episode intro (00:17)
- What is patent validation? (00:57)
- The do or die moment (02:37)
- Why is it useful to investigate the topic of validation strategies for pharma patents? (03:12)
- Where to begin in terms of deciding where to validate a pharma patent (04:30)
- Differences between the approach of Big Pharma to smaller companies (06:27)
- Key takeaways from the Special Report (07:08)
More about Mewburn Ellis Forward
Forward celebrates the most compelling developments taking place in the scientific and entrepreneurial worlds and covers the IP challenges that international organisations face every day. This podcast is part of our new Forward: On Demand series - video blogs (vlogs), podcasts and webinars available to watch or listen to at any time. View the full series here and the podcast series here.
Sign up to our monthly Forward newsletter to receive the latest news, insights, features and on demand content direct to your inbox each month.
Sign up to our newsletter: Forward - news, insights and features
We have an easily-accessible office in central London, as well as a number of regional offices throughout the UK and an office in Munich, Germany. We’d love to hear from you, so please get in touch.